INTERNATIONAL PATENT: GENAHEAD BIO,INC., 株式会社ＧＥＮＡＨＥＡＤ ＢＩＯ, JAPAN INSTITUTE FOR HEALTH SECURITY, 国立健康危機管理研究機構 FILES APPLICATION FOR "NUCLEIC ACID FOR USE IN TREATMENT OF SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS AND CONJUGATE OF TARGETING MOLECULE AND SAID NUCLEIC ACID"

GENEVA, Feb. 17 -- GENAHEAD BIO,INC. (26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa2510012), 株式会社ＧｅｎＡｈｅａｄ　Ｂｉｏ (神奈川県藤沢市村岡東二丁目２６番地の１　湘南ヘルスイノベーションパーク内), JAPAN INSTITUTE FOR HEALTH SECURITY (21-1, Toyama 1-chome, Shinjuku-ku, Tokyo1628655), 国立健康危機管理研究機構 (東京都新宿区...